THE EFFICACY AND SAFETY OF TOPIRAMATE FOR PROPHYLAXIS OF MIGRAINE IN CHILDREN

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

FALLAH RAZIEH; AKHAVAN KARBASI SEDIGHAH; SHAJARI AHMAD; FROMANDI MOSTAFA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Child Neurology Year:2013 | Volume:7 | Issue:4 Page(s): 7-11

Download Full-Text

View:

279

Download:

132

Cites:

Information Journal Paper

Title

THE EFFICACY AND SAFETY OF TOPIRAMATE FOR PROPHYLAXIS OF MIGRAINE IN CHILDREN

Author(s)

FALLAH RAZIEH | AKHAVAN KARBASI SEDIGHAH | SHAJARI AHMAD | FROMANDI MOSTAFA | Issue Writer Certificate

Keywords

HEADACHE

MIGRAINE

PROPHYLAXIS

TOPIRAMATE

Abstract

Objective MIGRAINE is the most common acute intermittent primary HEADACHE in children and prophylactic therapy is indicated in children with frequent or disabling HEADACHEs. The purpose of this study was to evaluate the efficacy and safety of TOPIRAMATE (TPM) for MIGRAINE PROPHYLAXIS in children.Materials&Methods In a quasi-experimental study, monthly frequency, severity and duration of HEADACHE, MIGRAINE disability, and side-effects were evaluated in 100 children who were referred to the Pediatric Neurology Clinic of Shahid Sadoughi University of Medical Sciences, Yazd, Iran from April 2011 to March 2012, and were treated with 3 mg/kg/day of TPM for three months.Results Fifty eight (57.4%) girls and 42 (41.6%) boys with the mean age of 10.46±2.11 years were evaluated. Monthly frequency, severity, and duration of HEADACHE decreased with treatment from 15.34±7.28 to 6.07±3.16 attacks, from 6.21±1.74 to 3.15±2.22, and from 2.28±1.55 to 0.94±0.35 hours, respectively, and the Pediatric MIGRAINE Disability Assessment score reduced with TPM from 32.48±9.33 to 15.54±6.16. Transient side-effects were seen in 21% of the patients, including hyperthermia in 11%, anorexia and weight loss in 6%, and drowsiness in 4%. No serious side-effects were reported.Conclusion TPM could be considered as a safe and effective drug in pediatric MIGRAINE PROPHYLAXIS.

Cites

No record.

References

No record.

Cite

APA: Copy

FALLAH, RAZIEH, AKHAVAN KARBASI, SEDIGHAH, SHAJARI, AHMAD, & FROMANDI, MOSTAFA. (2013). THE EFFICACY AND SAFETY OF TOPIRAMATE FOR PROPHYLAXIS OF MIGRAINE IN CHILDREN. IRANIAN JOURNAL OF CHILD NEUROLOGY (IJCN), 7(4), 7-11. SID. https://sid.ir/paper/303389/en

Vancouver: Copy

FALLAH RAZIEH, AKHAVAN KARBASI SEDIGHAH, SHAJARI AHMAD, FROMANDI MOSTAFA. THE EFFICACY AND SAFETY OF TOPIRAMATE FOR PROPHYLAXIS OF MIGRAINE IN CHILDREN. IRANIAN JOURNAL OF CHILD NEUROLOGY (IJCN)[Internet]. 2013;7(4):7-11. Available from: https://sid.ir/paper/303389/en

IEEE: Copy

RAZIEH FALLAH, SEDIGHAH AKHAVAN KARBASI, AHMAD SHAJARI, and MOSTAFA FROMANDI, “THE EFFICACY AND SAFETY OF TOPIRAMATE FOR PROPHYLAXIS OF MIGRAINE IN CHILDREN,” IRANIAN JOURNAL OF CHILD NEUROLOGY (IJCN), vol. 7, no. 4, pp. 7–11, 2013, [Online]. Available: https://sid.ir/paper/303389/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops